IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 130 filers reported holding IMMUNITYBIO INC in Q3 2022. The put-call ratio across all filers is 1.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $274,561 | +82.8% | 162,462 | +200.7% | 0.00% | 0.0% |
| Q2 2023 | $150,206 | +55.6% | 54,031 | +1.9% | 0.00% | – |
| Q1 2023 | $96,516 | -64.1% | 53,031 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $268,867 | +1.1% | 53,031 | -0.9% | 0.00% | 0.0% |
| Q3 2022 | $266,000 | +33.7% | 53,531 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $199,000 | +7.6% | 53,531 | +62.2% | 0.00% | 0.0% |
| Q1 2022 | $185,000 | -8.0% | 33,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $201,000 | -37.4% | 33,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $321,000 | -10.1% | 33,000 | +32.0% | 0.00% | 0.0% |
| Q2 2021 | $357,000 | -11.6% | 25,000 | +47.1% | 0.00% | -50.0% |
| Q1 2021 | $404,000 | – | 17,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Winning Points Advisors, LLC | 251,556 | $1,387,000 | 1.70% |
| ORACLE INVESTMENT MANAGEMENT INC | 315,322 | $1,567,000 | 0.89% |
| HARBOURVEST PARTNERS LLC | 335,709 | $1,668,000 | 0.54% |
| ALLEN HOLDING INC /NY | 687,571 | $3,417,000 | 0.54% |
| MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $479,000 | 0.21% |
| SHEETS SMITH WEALTH MANAGEMENT | 207,926 | $1,033,000 | 0.17% |
| Clearwater Capital Advisors, LLC | 185,911 | $924,000 | 0.13% |
| WEALTH EFFECTS LLC | 28,500 | $142,000 | 0.09% |
| Virtus ETF Advisers LLC | 35,048 | $174,000 | 0.07% |
| Vident Investment Advisory, LLC | 195,127 | $969,000 | 0.03% |